FRA:WDH1 • DK0060738599
The current stock price of WDH1.DE is 26.32 EUR. In the past month the price decreased by -10.96%.
ChartMill assigns a technical rating of 3 / 10 to WDH1.DE.
ChartMill assigns a fundamental rating of 5 / 10 to WDH1.DE. WDH1.DE scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months WDH1.DE reported a non-GAAP Earnings per Share(EPS) of 1.49. The EPS decreased by -3.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.73% | ||
| ROA | 3.95% | ||
| ROE | 15.7% | ||
| Debt/Equity | 1.94 |
26 analysts have analysed WDH1.DE and the average price target is 31.64 EUR. This implies a price increase of 20.21% is expected in the next year compared to the current price of 26.32.
For the next year, analysts expect an EPS growth of 26.65% and a revenue growth 11.85% for WDH1.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 15.85 | 107.471B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.08 | 46.665B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 17.51 | 25.662B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.86 | 25.325B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.26 | 25.287B | ||
| BIM | BIOMERIEUX | 19.56 | 11.954B | ||
| DIA | DIASORIN SPA | 16.91 | 3.97B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.51 | 3.711B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 10.81 | 2.308B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.91 | 1.672B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.
DEMANT A/S
Kongebakken 9
SMOERUM DK
Employees: 21278
Phone: 4539177300
Demant A/S engages in the development, manufacture, and sale of products and equipment designed to aid the hearing and communication of individuals. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The firm operates globally, through more than 90 subsidiaries and associates worldwide.
The current stock price of WDH1.DE is 26.32 EUR. The price increased by 10.22% in the last trading session.
WDH1.DE does not pay a dividend.
WDH1.DE has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on WDH1.DE.
The Revenue of DEMANT A/S (WDH1.DE) is expected to grow by 11.85% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
DEMANT A/S (WDH1.DE) has a market capitalization of 5.63B EUR. This makes WDH1.DE a Mid Cap stock.